Direct intraventricular injection of IGF-1, administered 30 minutes after stroke induction, was found to reduce infarct size and improve functional outcomes [121], while local application of IGF-1 to the cerebral cortex achieved similar effects in reducing infarct size and enhancing neuron survival [124]. This evidence concerns the gene IGF1 and Stroke.